Advancements in targeted drug delivery system: a review of novel approaches and carrier systems

Targeted drug delivery systems have transformed pharmaceutical sciences by enhancing therapeutic efficacy, reducing side effects, and improving patient compliance. This review article explores the evolution of drug delivery systems, highlighting the importance of targeted approaches in disease management. We examine the principles, advantages, and limitations of various carrier systems, including liposomes, nanoparticles, monoclonal antibodies, niosomes, and quantum dots. These systems demonstrate potential in delivering drugs specifically to the site of action, minimizing toxicity, and enhancing therapeutic outcomes. The article discusses challenges and future directions in targeted drug delivery development, emphasizing the need for further research in nanotechnology and biomaterials. By understanding targeted drug delivery systems' potential, researchers and clinicians can develop more effective and safer treatments. This review provides insights into the current state of targeted drug delivery, highlighting its potential to revolutionize disease management. The development of novel carrier systems and approaches is crucial for improving therapeutic outcomes and patient quality of life.